These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 2651861
1. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia]. Lohmöller G, Middeke M, Mrowka C, Pötzl C, Renner W, Zoller W. Med Klin (Munich); 1989 Feb 15; 84(2):81-5. PubMed ID: 2651861 [Abstract] [Full Text] [Related]
2. [Clinical significance of the ISA (intrinsic sympathomimetic activity) of the beta blocker carteolol]. Lohmöller G, Conca W, Pötzl C. Med Klin (Munich); 1987 Sep 18; 82(19):647-50. PubMed ID: 3683326 [No Abstract] [Full Text] [Related]
3. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol. Simon H, Schuppan U. Arzneimittelforschung; 1983 Sep 18; 33(2a):318-21. PubMed ID: 6340700 [Abstract] [Full Text] [Related]
4. [Clinical experiences with carteolol in patients with essential hypertension]. Viehmann P. Arzneimittelforschung; 1983 Sep 18; 33(2a):322-5. PubMed ID: 6340701 [Abstract] [Full Text] [Related]
5. [Clinical experiences in patients with coronary heart disease and angina pectoris]. Sölter H. Arzneimittelforschung; 1983 Sep 18; 33(2a):304-10. PubMed ID: 6404286 [Abstract] [Full Text] [Related]
6. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics]. Hugues FC, Le Jeunne C, Munera Y, Dufier JL. J Fr Ophtalmol; 1987 Sep 18; 10(8-9):485-90. PubMed ID: 2892874 [Abstract] [Full Text] [Related]
7. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile. Silke B, Nelson GI, Ahuja RC, Taylor SH. Postgrad Med J; 1983 Sep 18; 59 Suppl 3():45-52. PubMed ID: 6359109 [Abstract] [Full Text] [Related]
8. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol]. Werning C. Arzneimittelforschung; 1983 Sep 18; 33(2a):325-30. PubMed ID: 6682324 [No Abstract] [Full Text] [Related]
9. Intrinsic sympathomimetic activity (ISA) of pindolol in patients with sinus node dysfunction. Viersma JW, van den Berg MP, van Gilst WH, Lie KI. Eur Heart J; 1986 Jan 18; 7(1):42-6. PubMed ID: 3956521 [Abstract] [Full Text] [Related]
10. Pindolol therapy for bradycardia/tachycardia syndrome. Schamp DJ, Carliner NH, Peters RW. Can J Cardiol; 1987 Jan 18; 3(5):212-4. PubMed ID: 3607587 [Abstract] [Full Text] [Related]
11. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity. Giles TD, Sander GE, Roffidal L, Thomas MG, Mersch DP, Moyer RR, Burris JF, Mroczek WJ, Brachfeld J. Arch Intern Med; 1988 Aug 18; 148(8):1725-8. PubMed ID: 3041936 [Abstract] [Full Text] [Related]
12. [Clinical results with carteolol in patients with arrhythmias]. Strösser W. Arzneimittelforschung; 1983 Aug 18; 33(2a):339-45. PubMed ID: 6682327 [Abstract] [Full Text] [Related]
13. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect]. Kober G, Veidt J, Mikludy R, Kaltenbach M. Arzneimittelforschung; 1983 Aug 18; 33(2a):313-7. PubMed ID: 6682323 [Abstract] [Full Text] [Related]
14. Beta blockers with intrinsic sympathomimetic activity. White WB. Am Fam Physician; 1985 Jan 18; 31(1):115-8. PubMed ID: 2857059 [Abstract] [Full Text] [Related]
15. [Hypotensive effect of carteolol in patients with essential hypertension]. Beythien RD. Arzneimittelforschung; 1983 Jan 18; 33(2a):330-3. PubMed ID: 6682325 [Abstract] [Full Text] [Related]
16. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study]. Rosprich G, Sölter H. Arzneimittelforschung; 1983 Jan 18; 33(2a):334-9. PubMed ID: 6682326 [No Abstract] [Full Text] [Related]
17. Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension. Shimada K, Kawamoto A, Matsubayashi K, Chikamori T, Kuzume O, Ozawa T. Clin Ther; 1990 Jan 18; 12(2):118-24. PubMed ID: 1972351 [Abstract] [Full Text] [Related]
18. Ambulatory blood pressure and heart rate during once-daily, randomized, crossover administration of carteolol and atenolol. Saito K, Furuta Y, Sano H, Yokoyama M, Fukuzaki H. Clin Ther; 1994 Jan 18; 16(2):181-90. PubMed ID: 8062314 [Abstract] [Full Text] [Related]
19. Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy. Rosales OR, Sander GE, Roffidal L, Given MB, Giles TD. Chest; 1989 Jan 18; 95(1):43-7. PubMed ID: 2521204 [Abstract] [Full Text] [Related]
20. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension]. Serro-Azul JB, Wajngarten M, Santomauro A, Braga A, Yazbek Júnior P, Bellotti G, Serro-Azul LG, Pileggi F. Arq Bras Cardiol; 1989 Dec 18; 53(6):321-5. PubMed ID: 2700113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]